ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

22,211Medicare Part D Prescriptions Filled, Including Refills

Rank: 48 out of 2061

$1.32M Total Retail Price of All Prescriptions

Rank: 47 out of 2061

463 Patients Receiving at Least One Drug in Part D
68%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Ohio
Lower avg

Schedule Two
Controlled Substances

11% of this provider’s 463 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

11% of this provider’s 463 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

2% of this provider’s 13,411 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$60 was the average price of a prescription from this provider, compared to $61 among peers.

Prescriptions per Patient

48 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Ohio
LEVOTHYROXINE SODIUM 807 512 1 3
FUROSEMIDE 793 524 2 6
LISINOPRIL 644 383 3 2
OMEPRAZOLE 575 363 4 5
SIMVASTATIN 492 213 5 1
WARFARIN SODIUM 484 385 6 11
TRAMADOL HCL 455 296 7 18
GABAPENTIN 373 193 8 15
DONEPEZIL HCL 372 320 9 24
METOPROLOL TARTRATE 352 220 10 7
CITALOPRAM HBR 341 182 11 20
AMLODIPINE BESYLATE 333 238 12 4
POTASSIUM CHLORIDE 316 221 13 16
CLOZAPINE 273 0 14 164
CLONIDINE HCL 269 135 15 52
KLOR-CON M20 257 164 16 47
METFORMIN HCL 247 107 17 9
CARVEDILOL 243 150 18 22
CLOPIDOGREL 241 188 19 29
HYDROCODONE-ACETAMINOPHEN 239 178 S3 20 10
NOVOLOG 238 166 21 102
RISPERIDONE 234 122 22 66
LANTUS 218 155 23 48
DIVALPROEX SODIUM 205 43 24 74
NAMENDA 190 180 25 37
RANITIDINE HCL 189 92 26 53
SERTRALINE HCL 182 100 27 21
QUETIAPINE FUMARATE 176 85 28 72
BUSPIRONE HCL 173 87 29 115
GLIPIZIDE 168 99 30 55
PLAVIX 165 131 31 49
THEOPHYLLINE ANHYDROUS 159 119 32 201
LYRICA 158 139 33 83
MIRTAZAPINE 158 136 33 46
ENULOSE 157 31 35 262
TAMSULOSIN HCL 156 113 36 30
ALENDRONATE SODIUM 156 73 36 25
AZITHROMYCIN 154 94 38 34
DIGOXIN 143 118 39 56
GENERLAC 141 24 40 233
PROAIR HFA 140 33 41 40
LACTULOSE 139 37 42 131
CARBAMAZEPINE 121 47 43 187
LOSARTAN POTASSIUM 121 67 43 17
BENZTROPINE MESYLATE 120 35 R 45 149
NITROFURANTOIN 117 95 46 206
IPRATROPIUM-ALBUTEROL 113 108 47 117
ALLOPURINOL 113 73 47 28
JANUVIA 113 56 47 51
LEVETIRACETAM 111 24 50 102
POLYETHYLENE GLYCOL 3350 110 54 51 64
DIOVAN 109 78 52 41
SULFAMETHOXAZOLE-TRIMETHOPRIM 106 50 53 87
CIPROFLOXACIN HCL 106 80 53 54
NEXIUM 103 70 55 26
FAMOTIDINE 100 88 56 67
ALBUTEROL SULFATE 100 39 56 104
SPIRIVA 100 34 56 63
PREDNISONE 95 71 59 32
HYDRALAZINE HCL 95 47 59 69
CLOTRIMAZOLE-BETAMETHASONE 92 69 61 173
CEPHALEXIN 91 58 62 112
GLIMEPIRIDE 91 40 62 33
TRAZODONE HCL 90 59 64 39
ATORVASTATIN CALCIUM 90 34 64 8
OLANZAPINE 90 24 64 132
ATENOLOL 89 72 67 13
CEFTRIAXONE 84 80 68 228
KLOR-CON M10 84 43 68 125
SEROQUEL 81 49 70 157
FENTANYL 81 79 S2 70 84
ROPINIROLE HCL 79 47 72 92
CRESTOR 79 70 72 31
TOPIRAMATE 79 11 72 190
NITROFURANTOIN MONO-MACRO 78 66 75 162
ONGLYZA 78 72 75 204
METRONIDAZOLE 78 56 75 223
AMOXICILLIN 78 48 75 121
CYMBALTA 77 15 79 59
ZOLPIDEM TARTRATE 76 75 80 23
METOPROLOL SUCCINATE 75 63 81 19
EXELON 74 74 82 94
ESCITALOPRAM OXALATE 72 31 83 77
PANTOPRAZOLE SODIUM 72 40 83 45
NIASPAN 71 37 85 155
SPIRONOLACTONE 70 51 86 62
DIVALPROEX SODIUM ER 69 46 87 188
BACLOFEN 69 41 87 123
DICYCLOMINE HCL 67 42 89 207
CELEBREX 67 55 89 91
LANTUS SOLOSTAR 65 22 91 76
TIZANIDINE HCL 65 0 91 137
ADVAIR DISKUS 65 29 91 57
TRIAMTERENE-HCTZ 64 50 94 38
ISOSORBIDE MONONITRATE ER 64 46 94 42
PRISTIQ ER 64 39 94 376
ABILIFY 63 14 97 160
LOVAZA 63 15 97 191
CYCLOBENZAPRINE HCL 63 31 R 97 78
HYDROCHLOROTHIAZIDE 63 32 97 12
VIMPAT 62 24 101 353
FLUCONAZOLE 61 36 102 200
FLUOXETINE HCL 61 29 102 73
CARBIDOPA-LEVODOPA 61 61 102 97
LATUDA 60 0 105 502
LIDOCAINE HCL 59 55 106 290
FLUTICASONE PROPIONATE 59 20 106 43
VENLAFAXINE HCL 58 46 108 193
OXYBUTYNIN CHLORIDE 57 39 109 121
GEMFIBROZIL 56 0 110 107
IPRATROPIUM BROMIDE 55 23 111 167
HYDROXYZINE PAMOATE 54 19 R 112 360
AVELOX 54 46 112 254
KLOR-CON 10 54 35 112 141
PHENYTOIN SODIUM EXTENDED 54 17 112 145
METOLAZONE 53 44 116 212
TRAVATAN Z 52 29 117 245
PROMETHAZINE HCL 51 38 R 118 119
NOVOLOG FLEXPEN 51 32 118 177
VALPROIC ACID 50 22 120 220
DOXAZOSIN MESYLATE 50 38 120 81
MIDODRINE HCL 50 36 120 290
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 7, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.